Covid-19: is there a ‘twindemic’ coming?

Loading player...
As the UK heads into autumn, Covid-19 appears to be surging again. According to official data, 40,650 people tested positive in England in the seven days up to and including 24 September. This was an increase of 42% on the week before. But as we brace for another wave, experts are also concerned about a potential rise in influenza. Ian Sample speaks to Prof Peter Openshaw about the Omicron variant, why we’re at risk of a ‘twindemic’ this year and whether it’s time we all start taking more preventive measures. Help support our independent journalism at theguardian.com/sciencepod
4 Oct 2022 English United Kingdom Science · Nature

Other recent episodes

Can a name change transform PCOS outcomes for women?

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand…
21 May 16 min

Ebola outbreak: what do we know and can it be contained?

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, which has led to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular…
18 May 13 min

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link…
14 May 21 min

Trump is backing psychedelic research: here’s why

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise…
12 May 17 min